Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zipp

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Neural Transmission. Supplementum|August 30, 2003
Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion modelE Kwidzinski, L K Mutlu, A D Kovac, et al.
Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.
Neurology|September 23, 2009
Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatmentJ Dörr, A Bitsch, K J G Schmailzl, et al.
Brain, Behavior, and Immunity|May 31, 2011
BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesionsM Kipp, S Gingele, F Pott, et al.
Multiple Sclerosis and Related Disorders|February 4, 2019
Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosisS Grahl, V Pongratz, P Schmidt, et al.
Brain : a Journal of Neurology|July 17, 2009
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosisS Cotte, N von Ahsen, N Kruse, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Journal of Neuroinflammation|December 17, 2015
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MSL Schrewe, C M Lill, T Liu, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Neural Transmission. Supplementum|August 30, 2003
Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion modelE Kwidzinski, L K Mutlu, A D Kovac, et al.
Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.
Neurology|September 23, 2009
Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatmentJ Dörr, A Bitsch, K J G Schmailzl, et al.
Brain, Behavior, and Immunity|May 31, 2011
BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesionsM Kipp, S Gingele, F Pott, et al.
Multiple Sclerosis and Related Disorders|February 4, 2019
Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosisS Grahl, V Pongratz, P Schmidt, et al.
Brain : a Journal of Neurology|July 17, 2009
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosisS Cotte, N von Ahsen, N Kruse, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Journal of Neuroinflammation|December 17, 2015
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MSL Schrewe, C M Lill, T Liu, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.
Pageof 9